We use first and third-party cookies to offer our services and collect statistical data. If you continue browsing this website you accept their use. More information Accept
ABOUT US / NEURAXPHARM
EMPRESA_METAS_LOGOGROUP_ALT Inke is a subsidiary of EMPRESA_METAS_LOGOGROUP_ALT

A EUROPEAN LEADER IN PHARMACEUTICAL
PRODUCTS FOR THE CENTRAL NERVOUS SYSTEM (CNS)

Consolidated as a group in 2016, Neuraxpharm has a unique understanding of the CNS market of more than 30 years.

Neuraxpharm develops and commercializes in Europe branded and generic CNS pharmaceuticals and nutraceuticals, offering a wide range of effective, differentiated and affordable CNS treatments, aimed at patients as well as health professionals and industry partners.

Additionally, through our manufacturing companies Lesvi and Inke, Neuraxpharm has an international presence in more than 50 countries. We provide industry partners with finished dosage forms (FDFs) across multiple technologies and niche active pharmaceutical ingredients (APIs) using our expertise in the CNS and the respiratory areas.


NEURAXPHARM,
SPECIALIZED IN CNS 
SINCE 1985

NEURAXPHARM FAMILY MEMBERS

Neuraxpharm develops and commercializes branded and generic CNS pharmaceuticals and nutraceuticals related to the prevention of CNS indications in main European countries
Neuraxpharm also owns and operates two manufacturing plants in Spain
  • EMPRESA_METAS_BRAND04_PRODUC_ALT
    B2B solutions provider dedicated to the development and manufacturing of finished dosage forms (FDFs)
    MORE
  • EMPRESA_METAS_BRAND05_PRODUC_ALT
    Focused on the development and manufacturing of the highest quality active pharmaceutical ingredients (APIs) with complex synthesis processes
    MORE
BACKWARD INTEGRATION
The consolidation of all the companies within Neuraxpharm allows us to establish growth and cross-business operational synergies in strategic aspects such as R&D, manufacturing, procurement, cross-licensing and geographical expansion
MORE